Prospective Evaluation of Pyrosequencing for the Rapid Detection of Isoniazid and Rifampin Resistance in Clinical Mycobacterium Tuberculosis Isolates

Overview

Journal Eur J Clin Microbiol Infect Dis

Publisher Springer

Specialties Infectious Diseases
Microbiology

Date 2008 Aug 23

PMID 18719956

Citations 14

Authors

H J Marttila

J Makinen

M Marjamaki

H Soini

Affiliations

Soon will be listed here.

Abstract

A pyrosequencing-based method for the rapid detection of isoniazid (INH) and rifampin (RIF) resistance in Mycobacterium tuberculosis was evaluated in clinical practice. The method can detect the INH resistance-causing katG315 mutation, and all mutations in the RIF resistance-determining rpoB core region, in less than 6 h from cultured isolates. The method was first validated with 42 isolates, and was subsequently prospectively evaluated with 91 isolates, including clinical isolates and external quality control assessment strains, over a period of 2.5 years. The pyrosequencing results of clinical isolates were available, on average, 19 days earlier (median 19 days; range 3-43 days) than conventional susceptibility testing results. The composite data showed that the sensitivity of pyrosequencing for detecting resistance correctly was 66.7% for INH and 97.4% for RIF. The specificity of pyrosequencing was 100% for both drugs. Acceptable sensitivity for detecting resistance and the rapidness of pyrosequencing make it a valuable tool in the clinical setting.

Citing Articles

Targeted next-generation sequencing to diagnose drug-resistant tuberculosis: a systematic review and meta-analysis.

Schwab T, Perrig L, Goller P, Guebely De la Hoz F, Lahousse A, Minder B Lancet Infect Dis. 2024; 24(10):1162-1176.

PMID: 38795712 PMC: 11881551. DOI: 10.1016/S1473-3099(24)00263-9.

Pyrosequencing for diagnosis of multidrug and extensively drug-resistant tuberculosis: A systemic review and meta-analysis.

Getachew E, Adebeta T, Gebrie D, Charlie L, Said B, Assefa D J Clin Tuberc Other Mycobact Dis. 2021; 24:100254.

PMID: 34278006 PMC: 8267485. DOI: 10.1016/j.jctube.2021.100254.

Shedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis.

Georghiou S, Seifert M, Lin S, Catanzaro D, Garfein R, Jackson R BMC Infect Dis. 2016; 16:458.

PMID: 27576542 PMC: 5006534. DOI: 10.1186/s12879-016-1781-y.

Rapid Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates Directly from Clinical Samples by Use of Amplicon Sequencing: a Proof-of-Concept Study.

Colman R, Anderson J, Lemmer D, Lehmkuhl E, Georghiou S, Heaton H J Clin Microbiol. 2016; 54(8):2058-67.

PMID: 27225403 PMC: 4963505. DOI: 10.1128/JCM.00535-16.

Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant Tuberculosis.

Catanzaro A, Rodwell T, Catanzaro D, Garfein R, Jackson R, Seifert M PLoS One. 2015; 10(8):e0136861.

PMID: 26322781 PMC: 4556461. DOI: 10.1371/journal.pone.0136861.

References

Taniguchi H, Aramaki H, Nikaido Y, Mizuguchi Y, Nakamura M, Koga T . Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. FEMS Microbiol Lett. 1996; 144(1):103-8. DOI: 10.1111/j.1574-6968.1996.tb08515.x. View

Brown H . WHO identifies drug-resistant tuberculosis "hotspots". Former Russian states are worst affected, but lack of data from China hides true extent of disease. Lancet. 2004; 363(9413):951. DOI: 10.1016/s0140-6736(04)15823-6. View

Slayden R, Lee R, Barry 3rd C . Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis. Mol Microbiol. 2000; 38(3):514-25. DOI: 10.1046/j.1365-2958.2000.02145.x. View

Mdluli K, Slayden R, Zhu Y, Ramaswamy S, Pan X, Mead D . Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid. Science. 1998; 280(5369):1607-10. DOI: 10.1126/science.280.5369.1607. View

Jureen P, Engstrand L, Eriksson S, Alderborn A, Krabbe M, Hoffner S . Rapid detection of rifampin resistance in Mycobacterium tuberculosis by Pyrosequencing technology. J Clin Microbiol. 2006; 44(6):1925-9. PMC: 1489404. DOI: 10.1128/JCM.02210-05. View

Haanpera M, Huovinen P, Jalava J . Detection and quantification of macrolide resistance mutations at positions 2058 and 2059 of the 23S rRNA gene by pyrosequencing. Antimicrob Agents Chemother. 2004; 49(1):457-60. PMC: 538907. DOI: 10.1128/AAC.49.1.457-460.2005. View

Marttila H, Soini H, Eerola E, Vyshnevskaya E, Vyshnevskiy B, Otten T . A Ser315Thr substitution in KatG is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St. Petersburg area in Russia. Antimicrob Agents Chemother. 1998; 42(9):2443-5. PMC: 105851. DOI: 10.1128/AAC.42.9.2443. View

Telenti A, Honore N, Bernasconi C, March J, Ortega A, Heym B . Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J Clin Microbiol. 1997; 35(3):719-23. PMC: 229657. DOI: 10.1128/jcm.35.3.719-723.1997. View

Wada T, Maeda S, Tamaru A, Imai S, Hase A, Kobayashi K . Dual-probe assay for rapid detection of drug-resistant Mycobacterium tuberculosis by real-time PCR. J Clin Microbiol. 2004; 42(11):5277-85. PMC: 525196. DOI: 10.1128/JCM.42.11.5277-5285.2004. View

10.

Zhang M, Yue J, Yang Y, Zhang H, Lei J, Jin R . Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China. J Clin Microbiol. 2005; 43(11):5477-82. PMC: 1287806. DOI: 10.1128/JCM.43.11.5477-5482.2005. View

11.

Telenti A, Imboden P, Marchesi F, Lowrie D, Cole S, Colston M . Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet. 1993; 341(8846):647-50. DOI: 10.1016/0140-6736(93)90417-f. View

12.

Hazbon M, Brimacombe M, Bobadilla Del Valle M, Cavatore M, Guerrero M, Varma-Basil M . Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2006; 50(8):2640-9. PMC: 1538650. DOI: 10.1128/AAC.00112-06. View

13.

Isola D, Pardini M, Varaine F, Niemann S, Rusch-Gerdes S, Fattorini L . A Pyrosequencing assay for rapid recognition of SNPs in Mycobacterium tuberculosis embB306 region. J Microbiol Methods. 2005; 62(1):113-20. DOI: 10.1016/j.mimet.2005.02.004. View

14.

Dye C, Watt C, Bleed D, Hosseini S, Raviglione M . Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA. 2005; 293(22):2767-75. DOI: 10.1001/jama.293.22.2767. View

15.

Garcia de Viedma D, del Sol Diaz Infantes M, Lasala F, Chaves F, Alcala L, Bouza E . New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis. J Clin Microbiol. 2002; 40(3):988-95. PMC: 120260. DOI: 10.1128/JCM.40.3.988-995.2002. View

16.

Cardoso R, Cooksey R, Morlock G, Barco P, Cecon L, Forestiero F . Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil. Antimicrob Agents Chemother. 2004; 48(9):3373-81. PMC: 514764. DOI: 10.1128/AAC.48.9.3373-3381.2004. View

17.

Ohno H, Koga H, Kohno S, Tashiro T, Hara K . Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob Agents Chemother. 1996; 40(4):1053-6. PMC: 163262. DOI: 10.1128/AAC.40.4.1053. View

18.

Ronaghi M, Uhlen M, Nyren P . A sequencing method based on real-time pyrophosphate. Science. 1998; 281(5375):363, 365. DOI: 10.1126/science.281.5375.363. View

19.

De Beenhouwer H, Lhiang Z, Jannes G, Mijs W, Machtelinckx L, Rossau R . Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tuber Lung Dis. 1995; 76(5):425-30. DOI: 10.1016/0962-8479(95)90009-8. View

20.

Bakonyte D, Baranauskaite A, Cicenaite J, Sosnovskaja A, Stakenas P . Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania. Antimicrob Agents Chemother. 2003; 47(6):2009-11. PMC: 155844. DOI: 10.1128/AAC.47.6.2009-2011.2003. View